Because of the increasing prevalence of peripheral artery diseases, venus thromboembolism, coronary diseases, and other conditions, the global clot management devices market is expected to grow steadily. The ever-expanding pool of high-risk geriatric population also drives the market's pace. There has been a continuous growth in demand for embolectomy devices due to an evolution in the nature of clot management procedures and growing awareness among the patient population and healthcare professionals regarding the proven benefits of novel devices.
Furthermore, the recommendation by the USFDA for the use of clot retrieval systems as the basic therapy for stroke also facilitates the demand for these devices. Percutaneous thrombectomy currently leads the clot management device market with a market share of over 30%. Additionally, the neurovascular embolectomy segment will witness the fastest market growth throughout the forecast period. Perpetual investments and the technological development of these devices, making them more precise and cost-effective, drive this segment.
Hospitals and diagnostic centers are the major end-users of clot management devices. Hospitals are the most common users of clot management devices, accounting for more than 75% of revenue in 2017. A greater number of patients walking through hospitals and higher affordability are the key factors contributing to the dominance of this segment. Furthermore, better reimbursements also drive the growth of the hospital segment in the global clot management devices market. On the other hand, the diagnostics segment will register the fastest growth during the forecast period.
Based on regional demarcation, North America is anticipated to dominate the global market for clot management devices. The high prevalence of peripheral vascular and cardiovascular diseases, the greater existence of high-risk geriatric populations, the evolved scenario, and the domicile of major market players in the region all contribute to the dominance of the North American market. This market is mainly driven by technological innovation, so a constant influx of funding for research and development is implemented by major market players. Some of the key players in the global clot management device market include
The global clot management devices market is segmented on the following basis:
Product Type
Neurovascular Embolectomy Devices
Percutaneous thrombectomy devices
Embolectomy Balloon Catheters
Catheter-Directed Thrombolysis (CDT) Devices
Inferior Vena Cava Filters (IVCF)
End-use
Hospitals
Diagnostic Centers and Specialty Clinics
Geography
North America
U.S.
Canada
Europe
Germany
France
Italy
U.K.
Russia
Rest of Europe
Asia-Pacific
India
China
Japan
Rest of Asia-Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC Countries
South Africa
Rest of Middle East and Africa
Key players identified for the clot management devices market include but are not limited to:
Medtronic, vascular, Teleflex, Boston Scientific Corporation, Vascular Solutions, Inc., Edwards Lifesciences, and others
This report offers the following:
An analysis of several techniques, test types, and regions that would provide a clear understanding of the ongoing and future trends in the global clot management devices market
Assessment of market dynamics, such as drivers, restraints, and opportunities prevalent in the market
Quantitative assessment of the current market size and future estimations for the period from 2016 to 2026, along with CAGRs for the period from 2018 to 2026
Company profiles that will highlight key information about the imperative players operating in the global clot management devices market
Frequently Asked Questions:
The market for Clot Management Devices Market is expected to reach US$ XX Mn By 2026.
The Clot Management Devices Market is expected to see significant CAGR growth over the coming years, at XX%.
The report is forecasted from 2018-2026.
The base year of this report is 2017.
Medtronic, vascular, Teleflex, Boston Scientific Corporation, Vascular Solutions, Inc., Edwards Lifesciences are some of the major players in the global market.
